Life & Health Sciences
August 25, 2015
A physical therapy researcher with the IU School of Health and Rehabilitation Sciences at Indiana University-Purdue University Indianapolis has been awarded a $465,000 National Institutes of Health grant to optimize aerobic exercise training for patients with pulmonary arterial hypertension -- a goal that data suggests could reduce patient morbidity and mortality.
August 17, 2015
A biomedical engineering researcher at Indiana University-Purdue University Indianapolis has received a $419,000 National Institutes of Health grant to uncover why mechanical stimulation of bones increases their resistance to fractures.
August 14, 2015
The Indiana University Board of Trustees gave unanimous approval today for a 45,000-square-foot, $21.6 million expansion to the Indiana University School of Dentistry.
Indiana University reports strong research funding, philanthropy, economic development performance in FY 2015August 14, 2015
IU enjoyed one of its best years ever for research grants, private philanthropy and economic development activities in fiscal year 2015, providing further compelling evidence of IU's enormous positive impact on Indiana.
August 12, 2015
Lois B. Travis, M.D., Sc.D., has been named the Lawrence H. Einhorn Professor of Cancer Research at the IU School of Medicine and director of the Cancer Survivorship Research Program at the IU Simon Cancer Center.
August 6, 2015
The 37 students who make up the first class to begin the Master of Physician Assistant Studies program at IUPUI will record another first when they complete the program, created to help fill the need for health care practitioners.
July 30, 2015
Indiana University-Purdue University Indianapolis researchers led by Jesse Stewart of the School of Science, have received a $2.6 million grant from the National Institutes of Health to conduct the first randomized controlled trial to determine whether depression treatment can help prevent the development of cardiovascular disease.
July 20, 2015
Anagin LLC, a company launched by two Indiana University scientists to develop a novel treatment for post-traumatic stress disorder, has appointed Eric J. Messner as its first CEO.